-ATPase of cardiac sarcoplasmic reticulum. Extensive historical studies are reviewed to provide perspective on recent developments. Phospholamban gene structure, expression, and regulation are presented in addition to in vitro and in vivo studies of PLB protein structure and activity. Applications of breakthrough experimental technologies in identifying PLB structure-function relationships and in defining its interaction with the Ca 2/ -ATPase are also highlighted. The current leading viewpoint of PLB's mechanism of action emerges from a critical examination of alternative hypotheses and the most recent experimental evidence. The potential physiological relevance of PLB function in human heart failure is also covered. The interest in PLB across diverse biochemical disciplines portends its continued intense scrutiny and its potential exploitation as a therapeutic target.
I. INTRODUCTION
to b-adrenergic stimulation may be caused by increased calcium influx after cAMP-dependent phosphorylation of The molecular mechanisms regulating myocardial a sarcolemmal channel protein (86, 212) , whereas the accontractility through b-adrenergic stimulation, the famil-celerated rate of relaxation of b-adrenergic-stimulated iar ''fight-or-flight'' response, have been the object of sci-cardiac tissue has been suggested to result mainly from entific investigations for several decades. b-Adrenergic an increased rate of calcium uptake by the sarcoplasmic stimulation of intact hearts increases both the rate and reticulum in response to phosphorylation of phospholammagnitude of contraction and the rate of relaxation of ban (PLB), the principal protein phosphorylated in cardiac cardiac muscle (228) . These effects are believed to result sarcoplasmic reticulum (208) . from variations in the cytosolic calcium concentration After the discovery of PLB, early reviews described produced by alterations in calcium fluxes across the two the apparent role of PLB in regulation of calcium transport principal membrane systems, the sarcolemma and the sar-across the sarcoplasmic reticulum and sketched a comcoplasmic reticulum (212) . Since the discovery in the plex protein structure (3, 39, 111, 191, 208, 210, 216, 217) . 1960s of the role of cAMP as a second messenger and its Interest in PLB grew as structure-function details were activation of a protein kinase, the mediation of b-adrener-revealed experimentally, which suggested that PLB might gic effects by cAMP-dependent phosphorylation of spe-itself exhibit channel activity (7, 115, 193) , and recent cific proteins has been well established (58, 123, 171) . In compilations have updated descriptions of PLB structure heart tissue, targets of this kinase have provided im-(31, 37a, 197a). Other recent summaries have focused on portant leads in identifying key proteins of the myocardial the role of PLB in the regulation of myocardial function regulatory machinery (86). Thus it has been proposed that by catecholamines (36, 59, 95, 114, 200, 207) and the role of PLB in skeletal and smooth muscle (137) . The present the accelerated rate of cardiac contraction in response review attempts to provide a complete historical perspec-calmodulin-dependent protein kinases occurs independently and additively (16, 77, 128, 209, 240) , as does the tive of PLB structure and function studies as a framework for understanding better the current approaches to reveal-concomitant stimulation of calcium transport and ATPase activity (116, 179, 209) , although one study found nonaddiing the properties and physiological role of this unique protein.
tivity in stimulation of ATPase activity (32). Cardiac sarcoplasmic reticulum also contains an endogenous phosphatase activity, which is capable of reversing these phos-II. BRIEF HISTORY OF DISCOVERY phorylation effects (108, 117, 118, 147, 214, 240) . The OF PHOSPHOLAMBAN concentration of calcium required for half-maximal activation of the calcium pump and calcium transport (K Ca value) is decreased by Ç50% after cAMP-dependent phosPhospholamban was first identified in cardiac microsomes as a 22-kDa protein serving as the principal sub-phorylation of PLB (65, 215) and further decreased by additional phosphorylation of PLB by calcium/calmodustrate for cAMP-dependent protein kinase (125, 213, 247) . Lower-molecular-mass forms of phosphorylated PLB (7-lin-dependent protein kinase (116, 209) . Although the decrease in K Ca produced by phosphorylation may not seem 12 kDa) were later identified in sarcoplasmic reticulum vesicles (15, 87, 245) and shown to be interconvertible very impressive upon first consideration, in actuality, at low ionized calcium concentration (submicromolar calwith the 22-kDa form; boiling in SDS (124) or treatment with Triton X-100 (128) caused dissociation of the 22-kDa cium concentration) where the calcium pump is marginally active, phosphorylation of PLB by protein kinases form into the low-molecular-weight forms, which could be reassociated to the 22-kDa form by freezing overnight induces a substantial increase in calcium transport to levels increased by fourfold or greater (65, 190, 213) . These (124) . These observations led to an early proposal that PLB was a homodimer (128). Other intermediate forms results suggested that PLB phosphorylation increases the apparent affinity of the Ca 2/ -ATPase for calcium (208) . of phosphorylated PLB were subsequently observed in sarcoplasmic reticulum, prompting descriptions of PLB Several other lines of evidence suggested that dephosphorylated PLB acts as an inhibitor of the Ca 2/ -ATPase as a heterotrimer (140) or a homotetramer (105) . The development of a method to purify PLB in the dephos-and that phosphorylation releases the inhibition (78, 107, 202) . Sites of interaction between PLB and the Ca 2/ -ATPphorylated form, however, ultimately permitted determination that PLB is a pentamer of identical subunits (240) . ase and the functional consequences of this interaction have been examined with the recent aid of mutagenesis More recent studies of purified PLB and mutagenic variants have revealed considerable detail of PLB structure techniques and the development of practicable expression systems, described in section V. and subunit interactions, summarized in section III. In part because of the complexity of PLB structure, The physiological role of PLB in cardiac health and disease has been the source of much speculation. Phosits precise function and mechanism of action have been elusive. Phospholamban was originally implicated in the pholamban clearly is a mediator in the regulation of myocardial function by catecholamines through the cAMP casregulation of calcium transport across the cardiac sarcoplasmic reticulum by the correlation of cAMP-induced cade. Consistent with this, PLB is present in slow skeletal muscle as well as cardiac muscle, which both exhibit stimulation of calcium transport by the Ca 2/ -ATPase, with the predominant phosphorylation of PLB by the cAMP-cAMP-dependent stimulation of calcium transport, whereas PLB has not been identified in fast skeletal musdependent protein kinase (110, 125, 213, 215) . Because of its role as the principal substrate of cAMP-dependent cle, which lacks this response pathway (92, 109) . By use of antibodies to the purified protein, PLB has also been protein kinase in cardiac sarcoplasmic reticulum vesicles, Tada et al. (212, 213) named the protein phospholamban, detected in microsomal membranes prepared from several types of smooth muscle (180) , including membranes meaning ''phosphate receptor.'' The level of calcium transport stimulated by cAMP-dependent mechanisms was prepared from large and medium-sized arteries (35, 42, 44, 178) , although the highest content nevertheless remains in commensurate with the degree of phosphorylation of PLB (212, 217) . Phospholamban was also found to be the prin-the heart. A more widespread distribution of PLB in smooth muscle suggests it may play a broader regulatory cipal substrate of an endogenous myocardial calcium/calmodulin-dependent protein kinase (128) and is one of the role in the cardiovascular system. For example, in PLB knockout mice, tissue contractility is affected in both carfew proteins avidly phosphorylated in sarcoplasmic reticulum by both cAMP-dependent and calcium/calmodulin-diac (144) and smooth muscle (123a). Recent development of sensitive immunological techniques, viable recondependent protein kinases (16, 89, 106) . The enhanced rate of calcium transport stimulated by calcium/calmodu-stitution methods, and cell expression and transgenic model systems has enabled testing of current hypotheses lin-dependent protein kinase parallels the activity of the Ca 2/ -ATPase and phosphorylation of PLB (174) . Phos-regarding the physiological function of PLB, described throughout this review. phorylation of PLB by the cAMP-dependent and calcium/ nases, and the localization of this protein kinase activity the binding of calmodulin to PLB is marginal compared with the major calmodulin binding protein of the sarcoto cardiac sarcolemma and its absence from sarcoplasmic reticulum casts doubt on the physiological relevance of plasmic reticulum, the ryanodine receptor (189). Endogenous phosphatases of the sarcoplasmic reticulum are nonprotein kinase C phosphorylation of PLB (176) . Wegener et al. (242) found no evidence for in vivo PLB phosphory-discriminatory in their ability to dephosphorylate the serine phosphorylated by cAMP-dependent protein kinase lation by protein kinase C in perfused guinea pig hearts, an observation also demonstrated in intact guinea pig hearts and the threonine phosphorylated by the calcium/calmodulin-dependent kinase (118, 147) , although dephosphory-(40), in rat cardiac myocytes after administration of phorbol ester (63) , and in perfused rat hearts after a-adrener-lation at the cAMP-dependent site was suggested to occur by a cooperative mechanism (131) . Early studies noted gic stimulation (133) .
that phosphatidylinositol potentiated phospholamban Phosphorylation of PLB pentameric subunits by phosphorylation by cAMP-dependent protein kinase (203) cAMP-dependent protein kinase occurs by a random and that the phosphorylation of phosphatidylinositols by mechanism (131), whereas results of gel-mobility shift cAMP-dependent protein kinase occurred concurrently analysis have been interpreted to suggest that calcium/ with PLB phosphorylation (83) . However, these findings calmodulin-dependent phosphorylation proceeds by a cohave not been confirmed, and a role for phosphatidylinosioperative mechanism (82). Cross-linking and affinity-latol or other specific phospholipids in the PLB regulatory beling experiments have suggested that PLB binds calpathway has not been identified. modulin (139) , that calmodulin binding to PLB is inhibited by prior phosphorylation of PLB by either cAMP-depenAmino acid sequence analysis of purified PLB after phosphorylation revealed that the serine and threonine dent or calcium/calmodulin-dependent protein kinases (156), and that calmodulin binding may be a prerequisite residues phosphorylated uniquely and exclusively by cAMP-dependent and calcium/calmodulin-dependent profor PLB phosphorylation by the calcium/calmodulin-dependent protein kinase (198) . However, the role of this tein kinases, respectively, are adjacent (193), refuting an early proposal espousing two distinct PLB polypeptides proposed calmodulin binding to PLB in the functional regulation of the Ca 2/ -ATPase by PLB is unsupported, and of slightly different molecular weights, each bearing a FIG. 2. Amino acid sequences of PLB monomer from different species, deduced by cDNA cloning. Amino acid sequences are presented in 1-letter amino acid code, with residue numbers indicated in top margin. Approximate cytoplasmic and transmembrane domains are bracketed. Solid circle and box designate serine-16 and threonine-17, respectively, the 2 phosphorylated residues. Dots indicate identical residues in all isoforms. Sequences were obtained from the following references: dog (53), pig (231), rabbit (50), rat (76) , mouse (55), human (54), chicken (227).
single site phosphorylated by one or the other protein transcribed from cDNA of the PLB sequence was used to confirm that PLB spontaneously forms pentamers both in kinase (25). Elucidation of the complete PLB primary structure by Fujii and co-workers by amino acid sequenc-the presence and in the absence of microsomes (33, 194) . ing (49) and cloning of the cDNA (53) firmly established Interestingly, PLB expressed in Escherichia coli caused the molecular mass of each monomer to be 6,080 Da and cell lysis, restricting the utility of this synthetic route, but confirmed the hypothesis that oligomeric PLB is a pen-strengthening the hypothesis that PLB may exhibit poretamer of 5 identical subunits (90, 240, 241), each con-forming activity (33, 115) . With the use of mass spectrometaining only 52 amino acids (Fig. 2) . Serine-16 and threo-try and direct sequence analysis to monitor purification nine-17 were identified as the residues phosphorylated by efforts, a successful protocol was eventually developed cAMP-dependent protein kinase and by calcium/calmodu-for isolation of authentic PLB in organic solvents (18) ; the lin-dependent protein kinase, respectively (53, 193). Con-PLB was phosphorylatable with cAMP-dependent protein sistent with earlier experimental evidence that PLB was kinase and formed pentamers in SDS, indicating retention composed of two domains (241), analysis of the PLB se-of these ''functional'' properties. However, aggregation quence by hydropathic profiling and secondary structure was a problem after purification of PLB with use of orpredictive algorithms (53, 193) suggested a structure com-ganic solvents (18) . Although by the original method for prised of a hydrophilic, cytoplasmically oriented amino-purification of PLB a considerable amount of protein terminal domain containing the phosphorylation sites and could be isolated sufficient for detailed biochemical studa carboxy-terminal hydrophobic domain anchoring the ies (3-5 mg of highly purified PLB were isolated routinely protein in the membrane (Fig. 2) . The hydrophobic region from sarcoplasmic reticulum vesicles prepared from 18-was predicted to form a helix sufficiently long to traverse 20 dog hearts; Refs. 90, 91), it is now possible to purify the sarcoplasmic reticulum membrane and, when assem-PLB by monoclonal antibody affinity chromatography bled into the pentameric oligomer, to form a domain re-after expression of the protein in insect cells using the sembling a channel structure (193) (Fig. 1) . The sequence baculovirus cell expression system (181) . By this method, of PLB from several species is shown in Figure 2 , illustrat-15-20 mg of recombinant wild-type or mutant PLB are ing the highly conserved primary structure of the protein. typically isolated at a time (181, 182, 194) . The recombinant protein behaves identically as the native protein: it Determination of the amino acid sequence of PLB (49, 53, 193) promoted the development of more specific is isolated as a pentamer with oligomeric mobility forms indistinguishable from the natural protein ( Fig. 3 ) and methods for its detection, quantitation, and characterization, including the development of specific cDNA and anti-retains the phosphorylation-induced mobility shifts, it exhibits a blocked amino terminus, and it reconstitutes funcbody probes. Alternative methods for preparation of PLB were soon reported thereafter. Immunoaffinity chroma-tionally with the cardiac or skeletal muscle calcium pumps like native PLB (181, 182) . Recently, PLB has been tography from deoxycholate-solubilized sarcoplasmic reticulum vesicles yielded PLB that exhibited pentamers in prepared by complete chemical synthesis using standard peptide synthesis and purification methods in organic sol-SDS (201) , like the protein purified from Zwittergent 3-14 (90) or C 12 E 8 (49), supporting the belief that oligomeric vents and exhibited biochemical characteristics similar to native PLB (152, 235) . The ready availability of large assembly is an inherent property of PLB and is independent of the method of PLB preparation. Knowledge of the quantities of recombinant and synthetic PLB should greatly facilitate future studies directed toward its bio-PLB sequence enabled access to recombinant methods for its de novo synthesis. In vitro translation of mRNA chemical and structural characterization.
noting that the complete PLB sequence is predominantly helical in aqueous solutions (196) and is almost entirely helical in 1:1 chloroform/methanol (151). However, the transmembrane hydrophobic helix at the carboxy terminus comprises only one-half or less (°50%) of the total residues and structure of PLB (53). This suggests that other residues in the sequence must also form a helix to account for the predominantly helical structure of the overall protein. The results further suggest that anchoring the PLB cytoplasmic domain to the carboxy-terminal half of the protein alters short-range interactions to promote this helical structure.
Given the apparent instability of structure in the PLB cytoplasmic domain, it should perhaps not be surprising that phosphorylation effects on secondary structure have so far been inconclusive. Circular dichroism measurements of the cytoplasmic domain in organic solvents suggested that phosphorylation results in a decrease in helicity by 6% (221), 11% (70) , and 33% (160), although in aque- Results from nuclear magnetic resonance in trifluoroeth{Boil indicates whether samples were boiled in SDS before electrophoresis. Numbers 1-5 designate monomeric through pentameric mobility anol suggest an unwinding of helix at residue 12 and the forms of PLB. Note that boiling in SDS causes partial destabilization of following residues after phosphorylation (160), but in arginine-14 and serine-16(P) may induce or stabilize a nascent helix in this region (160, 177). The transient and inducible nature of the cytoplasmic PLB structure, which The secondary structure of PLB as well as the amount and type of short-range interactions forming helix or b-is sensitive to its environment, may partly account for these discrepant experimental observations concerning sheet have been estimated by numerous spectroscopic studies. Circular dichroism spectroscopy of aqueous de-which specific residues in this peptide adopt a helical configuration and how phosphorylation may affect the tergent solutions of PLB shows it to be predominantly helical (68-78%) (152, 196, 235) . Similar results were ob-secondary structure.
The propensity of PLB monomers to self-associate tained by attenuated total reflection-Fourier transform infrared spectroscopy of PLB reconstituted in phospholipid forming an oligomeric structure was recognized using electrophoretic analysis soon after its discovery. Howbilayers, in which PLB was 64-77% helical (10, 220). Examination by circular dichroism of the pentameric hy-ever, deviation from ideal electrophoretic behavior often seen with membrane proteins and low-molecular-weight drophobic domain of PLB residues 26-52 in SDS showed it to be a very stable helix (67-90%) (196), a finding con-peptides caused early confusion regarding the number and nature of PLB subunits that associate. Subsequently, firmed by attenuated total reflection infrared spectroscopy of the membrane-domain assembly reconstituted in gel filtration in SDS with postcolumn detection by laser light scattering (238) supported the model of a pentameric phospholipid bilayers (73-82% helical), which also showed the membrane-spanning complex to orient pre-quaternary structure deduced from the electrophoretically resolved oligomeric mobility forms ( Fig. 3 showing dominantly perpendicular to the membrane (10, 143, 220). In marked contrast, the cytoplasmic domain of PLB stud-pentameric through monomeric mobility forms) and from the 10 discrete phosphorylation-induced mobility shifts in ied in isolation in aqueous solutions by circular dichroism spectroscopy (70, 160, 221) or nuclear magnetic reso-the pentamer after graded phosphorylation by cAMP-and calcium/calmodulin-dependent protein kinases (32, 77, nance (70, 160 , 177) appears devoid of stable secondary structure. Rather, it appears as a flexible domain, rapidly 240, 242) (Fig. 4) . The preferred assembly into pentamers was also suggested by gel filtration in deoxycholate and interconverting between transient conformers (70, 177) . However, the latent helix-forming potential predicted by sucrose density centrifugation in the presence or absence of octyl glucoside (61) . The agreement in this latter from the sequence of this domain (53) is manifested in the helix-stabilizing solvent trifluoroethanol, in which it hydrodynamic study may be serendipitous, however, because no attempt was made to correct for detergent bindexhibits 33-60% helix (70, 160, 221 ments failed to detect higher order oligomers than dimers the substituted side chain increased, implicating a steric or surface area-related component in disruption of the of PLB in sarcoplasmic reticulum vesicles (251), the observation that purified PLB or the hydrophobic domain oligomeric interactions.
With the design of other mutagenesis experiments to of PLB residues 26-52 displays conductance properties classically attributed to channels suggested that PLB at focus on the role of PLB hydrophobic residues, it was noted that the heptad repeat of leucines at positions 37, 44, and least transiently forms a pentameric pore structure in membranes (115) . Recent experiments using electron 51 conforms to the structural motif of a leucine zipper, and the further heptad repeat of isoleucines at positions 40 and paramagnetic resonance spectroscopy on lipid-reconstituted recombinant PLB have verified that it is present pri-47 renders an overall 3-4 residue repeat spacing characteristic of a coiled coil (195) . Specific replacement of any of marily as a pentamer in the lipid bilayer (34). However, in the dephosphorylated form, a substantial fraction of these individual residues with alanine prevented PLB pentamer formation, indicating their essential involvement in monomers is also present, contributing Ç20% of the total PLB protein and giving a molar ratio of Ç1:1 for pentam-the oligomeric assembly (194) . Experiments to probe the sensitivity of the PLB pentamer to individual mutations of ers to monomers. Remarkably, the proportion of pentameric PLB species in the membrane approaches 100% after other nonzipper residues to alanine enabled mapping of the surface orientations of these sequence positions. The PLB phosphorylation. This suggests that electrostatic repulsion between the cytoplasmic head groups of PLB may quaternary structure of PLB was thus proposed to be a coiled-coil symmetric structure containing a central pore inhibit pentamer formation. Phosphorylation of PLB, which changes the isoelectric point from 10 to 6.7 (90), defined by the specific hydrophobic surface interactions of the five stabilizing leucine/isoleucine zippers, which are may reverse this charge repulsion and allow complete oligomerization. This change in oligomeric size due to oriented to the interior and form the backbone of the pentamer (194, 195) (Fig. 5 ). phosphorylation is not detected under SDS-PAGE or high ionic strength conditions, probably because the electroAn alternate approach by Arkin et al. (8) used saturation mutagenesis of a chimeric protein construct in which static effects are screened by SDS or high concentrations of ions (34).
Staphylococcal nuclease (a monomeric soluble domain) was fused to the amino terminus of PLB. It was found that The specific residues that interact to create the pentameric structure of PLB are confined to the carboxy-the chimeric fusion protein formed pentamers like native PLB and was independently observed that the mutationally terminal hydrophobic domain (8, 193, 194, 241) . To probe the involvement of polar residues within this domain in sensitive residues of PLB forming the oligomers lined up on faces of a 3.5-residue/helical turn coiled-coil configurathe formation of PLB quaternary structure, site-specific mutants of PLB were studied by Fujii et al. (51), who first tion (8). To map the orientation of the cysteine sulfhydryls in the membrane-embedded domain of PLB, exchange of expressed the protein in mammalian cells. Replacement of the polar glutamine residues at sequence positions 22, the sulfhydryl S-H to S-D was examined with a synthetic peptide composed of residues 25-52 of PLB, which was 23, 26, and 29 and the asparagine residues at positions 27 and 30 with either alanine or the respective acid forms of purified from organic solvents (9). The results supported the model of a stable, membrane-associated oligomer of each amide residue had no effect on the thermal stability of the PLB pentamer as monitored by electrophoresis, PLB and suggested that only one sulfhydryl, that of cysteine-41, is able to exchange and thus is oriented toward the indicating their lack of involvement in PLB oligomers (51). However, mutation of the cysteines at positions 36, 41, outer surface of the structure where it may exchange with water diffused in the bilayer. However, the pentameric assoand 46 to serine, alanine, or phenylalanine indicated that PLB quaternary structure is sensitive to changes at these ciation of the peptide was not verified in this study (9) .
Although PLB models generated from the two surface mapsites and is most intolerant of changes in cysteine-41 (51). Pentamer formation and stability decreased as the size of ping studies agree on the general orientation of the PLB FIG. 5 . Heptad repeat cartoon model of PLB monomer and pentamer. A: residues 37-52 of monomeric PLB are configured as a 3.5-residues/turn helix with positions a-g of heptad repeat circled. Leucine and isoleucine residues constituting zippers are localized to positions a and d, respectively. Changing any of these circled residues to alanine destabilizes pentamer. B: PLB pentamer. Leucine residues interacting at position a and isoleucine residues interacting at position d stabilize the pentameric quaternary structure along the length of the transmembrane helix. [From Simmerman et al. (194).] helices (37a), the model interpreted from the sulfhydryl ments capable of modulating PLB gene expression. In exchange results suggests that four of the seven PLB helical humans, the PLB gene has been mapped to chromosome faces are occluded from lipid exposure (9), whereas the 6.q22.1, distant from the cardiac Ca 2/ -ATPase gene, which model derived from the specific mutagenesis results sug-is located on chromosome 12 (54, 172a). Thus transcripgests that only two helical faces, those of the leucine/isoleu-tional regulation of the calcium pump and its regulator, cine zippers, are completely unavailable for lipid interaction PLB, are not controlled by a simple, spatially linked mech- (194) . A recent detailed study, which uses a computational anism. Only a single type of PLB molecule has been found method in combination with computerized analysis, has in all species examined; there do not appear to be any compared the merits of the two models by critically as-alternative splice isoforms of the protein. The remarkable sessing the role of the leucine/isoleucine zipper region in conservation of the PLB sequence is evident in Figure 2 . pentamer stability (64a). High-resolution methods such as Phospholamban gene expression has been probed in crystallography and nuclear magnetic resonance will ulti-various tissue sources from several species. Messenger mately be needed to resolve the fine details of PLB quater-RNA of different sizes has been isolated from the dog nary structure, however (37a). Indeed, recently, the crystal (229), rabbit (50), pig (231), and chicken (227), most likely structure has been determined for a five-stranded coiled-representing use of different poly(A) attachment sites in coil protein, the cartilage oligomeric matrix protein (149), the 3-untranslated regions. Among mammalian, avian, which bears a remarkable similarity to the model proposed amphibian, and fish species, protein expression levels of for PLB (194, 195) .
PLB and calcium transport activity were compared, and the results provided an early suggestion that the proportion of PLB and Ca 2/ -ATPase expressed may not be con-IV. PHOSPHOLAMBAN GENE STRUCTURE, stant, but may differ depending on the species source EXPRESSION, AND REGULATION (244) . In this study, however, the existence of PLB in hearts of lower vertebrates (frog and carp) was suggested The PLB gene is highly conserved and present in sinonly by phosphorylation and was not verified with use gle copy in the genome of mammalian (54, 85, 144) and of a specific antibody or by other more direct methods. avian (227) species. One exon encodes the 52-amino acid Isolation and comparison of PLB cDNAs from mammalian protein in the rabbit (54), rat (85) , mouse (60a, 144), and smooth muscle and cardiac tissue demonstrate the identichicken (227). An unusually long intron is present in the cal nucleotide sequence (76, 231), as expected for the 5-untranslated region in all these species. A highly conpresence of a single-copy gene (54, 85, 144). However, served region within the first 113 base pairs of the 5-flank expression of the gene is tissue specific, with less PLB of the PLB gene was found in mammals (85) . Potential mRNA seen in smooth muscle than in cardiac muscle (42, consensus cis-promoter elements similar to known mus-76), consistent with immunological probes of PLB tissue cle-specific promoters have been identified (54, 85, 227), distribution and protein expression levels (42, 180) and and a recent study suggests that a GATA-4 motif may be by relative PLB phosphorylation levels in aortic versus especially important for cardiac-specific PLB gene exprescardiac tissue (24, 239). Disparate expression of PLB relasion (60a). In this same study (60a), enhancer regulatory tive to the Ca 2/ -ATPase has also been observed in pig elements were located at least 600 base pairs upstream smooth muscle tissues (42). Stomach, ileum, pulmonary from the transcription start point, and evidence was presented that the PLB intron may contain repressor ele-artery, and aorta from pig all showed comparable levels of calcium pump mRNA and protein (SERCA2 isoform), muscle, (20) and certain smooth muscles (178, 239) , exhibit ratios of expression of PLB to SERCA2 that are equal whereas PLB mRNA and protein varied over a 12-fold range, with depleted amounts of PLB detected in the pul-to those present in heart, but nonetheless have poor functional coupling between the two proteins (230). Other monary artery and aorta (42). However, much more PLB was detected in canine and bovine aorta (41, 180). It is functions for PLB in these tissues have been proposed, but none has yet been demonstrated. There is one report obvious from these results that expression of the cardiac calcium pump (SERCA2) and PLB are not always coordi-that PLB may regulate a chloride channel in sarcoplasmic reticulum (37). Recent results with PLB knockout mice nately regulated, as further exemplified from results of hormonal treatments, as discussed below.
(136a, 196b) and transgenic mice overexpressing PLB in skeletal muscle (196a) suggest that PLB plays a physiologThree Ca 2/ -ATPase genes (SERCA1, SERCA2, and SERCA3) exist encoding the 100,000-kDa sarcoplasmic re-ical role in skeletal muscle, but its regulatory effects on the calcium pump and contractility in this tissue nevertheticulum/endoplasmic reticulum calcium pumps in intracellular membranes (21) . In heart and slow-twitch skeletal less remain much less impressive than that in cardiac muscle. Fortunately, several cell culture systems useful muscle, only the SERCA2a pump is expressed significantly (137) , which originates as an alternative splice vari-for expression of recombinant PLB and SERCA2, employing COS-1 cells (224, 231), HEK-293 cells (223), and ant from the SERCA2 gene and is the main isoform coupled to PLB. In smooth muscle, the SERCA2b isoform is Sf21 insect cells (11, 12), maintain efficient coupling between the two expressed proteins and are now utilized mainly expressed, which is identical to SERCA2a except for the presence of an extended tail of 49 amino acids widely for investigational purposes.
Discoordinate regulation of the expression of PLB replacing the carboxy terminal four residues of SERCA2a. In fast-twitch skeletal muscle, the SERCA1 gene is pre-and the Ca 2/ -ATPase in heart is exemplified from results of thyroid hormone treatment. Treatment of rabbits with dominately expressed, whereas the SERCA3 gene product is found at low levels in a wide variety of tissues (21, 137) . thyroid hormone resulted in a 67% elevation in Ca 2/ -ATPase mRNA and a 39% decrease in PLB mRNA levels, SERCA1a is the predominant alternative splice isoform of the calcium pump expressed in adult fast-twitch skeletal whereas hypothyroidism evoked a 49% reduction in Ca 2/ -ATPase mRNA with no effect on the level of PLB mRNA muscle (21) .
Phospholamban expression can be induced in fast-(165). Similar trends in response to thyroid hormone have been obtained in rats by monitoring PLB and Ca ATPase proteins directly (13, 113). In these latter three changes the phenotype of the muscle from fast twitch to slow twitch. Under these conditions, the skeletal muscle studies, calcium uptake into cardiac sarcoplasmic reticulum was increased with hyperthyroidism and decreased isoform of the Ca 2/ -ATPase (SERCA1a) is concurrently switched to the isoform found in slow-twitch and cardiac with hypothyroidism, as originally observed by Suko (199) . With hyperthyroid rat hearts, the rate of cardiac tissues (SERCA2a) (19, 126) . With the use of quantitative immunoblotting with specific antibodies, proportions of relaxation was increased, and in sarcoplasmic reticulum vesicles isolated from these hearts, the apparent affinity PLB and SERCA2a were found to be nearly identical in canine cardiac, slow-twitch, and chronically stimulated of the calcium pump for calcium was also increased, as predicted from the decreased levels of PLB expression fast-twitch tissues (20). However, functional analysis of the regulatory effect of the PLB on the Ca 2/ -ATPase in found relative to expression of the calcium pump (13, 113). Therefore, it seems likely that alteration of the ratio each type of tissue indicated that PLB is not tightly coupled to the calcium pump in the slow-twitch or chronically of PLB to SERCA2a with the thyroid hormone state produces significant mechanical effects, but changes in levels stimulated fast-twitch muscle, in that calcium transport and Ca 2/ -ATPase activity in sarcoplasmic reticulum vesi-of other proteins including ratios of myosin isoforms (113a) should also be considered as accounting for concles from these tissues were poorly stimulated (2-fold or less) by a monoclonal antibody that reverses the PLB tractile effects. Observations of the effects of thyroid hormone on heart have led to the hypothesis that there may inhibitory effect (20) . A recent analysis of the time course of mRNA and protein expression during chronic stimula-be two ways in which PLB regulates Ca 2/ -ATPase activity: 1) a quick-acting, short-term mechanism involving PLB tion of fast-twitch skeletal muscle indicated a close correspondence between the appearance of PLB mRNA and phosphorylation and derepression of calcium pumping activity, and 2) a slower acting but longer term process PLB protein, whereas induction of the SERCA2a protein lagged behind expression of its mRNA (68) . A follow-up involving a change in the molecular ratio of PLB to the Ca 2/ -ATPase brought about by control of gene expression study indicated that the transcription rates of the SERCA2 and PLB genes in chronically stimulated fast-twitch skele- (104, 113) .
Phospholamban gene expression during embryonic tal muscle are discoordinately regulated (68a). Incompletely understood is why some tissues, viz. slow skeletal development of the heart appears to be regulated
09-01-98 19:46:53 pra APS-Phys Rev uniquely. Phospholamban mRNA has been detected in tion) (20, 22, 88, 101, 152, 159) . Kirchberger and co-workers (5, 5a) have recently challenged the tenet that the murine embryos very early in gestation at the time when spontaneous contractions are first observed (55). In chick main regulatory effect of phospholamban is on the calcium affinity of the calcium pump; however, the vast preembryos, expression of PLB mRNA is suppressed relative to cardiac a-actin transcripts, suggesting that PLB follows ponderance of data concur that the K Ca value is primarily affected. Although some investigators have reported that an independent expression program despite the presence of several putative muscle-specific promoter elements in synthetic peptides corresponding to the cytoplasmic domain of PLB have substantial inhibitory effects on the the 5-flanking region of its gene (222). In the developing rat heart, mRNA for the Ca 2/ -ATPase appears 3 days be-SERCA enzymes measured at saturating calcium concentration (74, 187) , this effect has not been found by others fore the expression of PLB mRNA, and the mRNA of the two proteins are expressed in opposite patterns along the (28, 88, 181, 234) and, moreover, does not appear to be functionally relevant because intact PLB does not signifiembryonic cardiac tube, with the calcium pump mRNA most abundant in the upstream part of the cardiac tube cantly affect the V max of the enzyme as cited above. Direct phosphorylation of the calcium pump by calcium/calmodand the richest amount of PLB mRNA in the downstream compartments. The results suggest that there are region-ulin-dependent protein kinase was recently reported to stimulate the V max of the enzyme, independently of any specific programs of PLB and Ca 2/ -ATPase gene expression that may account for the functional differences in involvement of PLB (223, 249). Phosphorylation of the calcium pump and V max effects were not observed precontractile properties between cardiac compartments (157) . Both Mahony and Jones (148) and Szymanska et viously by other investigators, however, and these results were recently disputed (discussed in detail by Reddy et al. (204) have observed that the protein levels of PLB and SERCA2a are decreased in neonatal mammalian heart al., Ref.
182). Mutagenesis work with recombinant
SERCA2a suggested that the site of ATPase phosphorylacompared with adult heart, which may account in part for the decreased contractile reserve of neonatal heart tion was serine-38 (223), but in-depth investigation of the effect of serine-38 phosphorylation revealed that any apand its blunted response to b-adrenergic agonists.
parent V max effects attributed to it resulted from artifacts of incubation (172) . Thus the major regulatory effect on V. MECHANISM OF CALCIUM PUMP the cardiac calcium pump is mediated by phosphorylation REGULATION IN SARCOPLASMIC of PLB, and this regulatory effect is to increase the cal-RETICULUM cium sensitivity of the enzyme. As a result of studies of the types above, it was proposed that PLB in the dephosphorylated state is an inhibitor of the Ca 2/ -ATPase (78) Concurrent with the identification of PLB as the principal membrane substrate for cardiac protein kinases, the and that phosphorylation of PLB removes this inhibition by increasing the enzyme's apparent calcium affinity (reeffect of PLB phosphorylation on calcium transport by the calcium pump (SERCA2a) of sarcoplasmic reticulum viewed in Ref. 210 ). Subsequent studies have been directed toward elucidating the mechanism of this calcium was investigated. The predominant, physiologically relevant effect of PLB phosphorylation is to increase the ap-pump suppression by PLB.
Early studies assessing the mechanism of PLB action parent affinity of the transport ATPase for calcium (usually expressed as a decrease in the K Ca value, or the ion-on the cardiac calcium pump used transient state analysis of ATPase activity and calcium transport to distinguish ized calcium concentration required for half-maximal activation of the pump), with little or no effect of phos-several kinetic steps in the reaction cycle (120, 218). In particular, when PLB in cardiac sarcoplasmic reticulum phorylation on the maximal velocity of the enzyme (V max ) as measured at saturating ionized calcium (ú1 mM) con-vesicles was phosphorylated by cAMP-dependent protein kinase, a marked increase occurred in the rate of a step centration. Both calcium transport and ATP hydrolysis by the pump are affected equally. This effect of PLB phos-associated with calcium binding to the enzyme and the rate at which the acylphosphoprotein intermediate was phorylation to increase the calcium affinity of the calcium pump, with little or no effect on the V max , has been demon-formed (218) . However, from these types of kinetic studies one could not discern if phosphorylation of PLB distrated consistently and reproducibly by numerous investigators after phosphorylation of PLB by cAMP-dependent rectly affected the equilibrium calcium-binding affinity of the pump or, instead, caused an apparent increase in calprotein kinase (27, 32, 65, 78, 101, 107, 172, 179, 215, 246) , calcium/calmodulin-dependent protein kinase (60, 172 , cium affinity by accelerating a kinetic step. It was important to distinguish these two alternatives, because they 174), or both kinases together (32, 116, 172). Identically, monoclonal antibodies directed to the phosphorylation have different mechanistic implications relevant to how phospholamban regulates the calcium pump. domain of PLB increase the sensitivity of calcium activation of SERCA2a, with little or no effect on the pump in cardiac sarcoplasmic reticulum vesicles directly, of PLB greatly accelerates this slow transition. Future studies will continue to address the molecular mechanism under equilibrium binding conditions. The measurements were made in the presence and absence of a monoclonal by which phosphorylation of PLB accelerates the ratelimiting steps of enzyme turnover, giving an apparent inantibody to PLB, which removes the PLB inhibitory effect in analogy to phosphorylation (190) . When calcium trans-crease in calcium affinity. Suzuki and Wang (202) first demonstrated that incubaport into cardiac sarcoplasmic reticulum vesicles was measured, the monoclonal antibody shifted the calcium tion of cardiac sarcoplasmic reticulum vesicles with a monoclonal antibody recognizing only PLB increased the concentration dependence for activation of transport to the left, but in the same sarcoplasmic reticulum vesicles, calcium pump activity in identical fashion as the stimulation occurring with PLB phosphorylation, confirming that PLB, the antibody had no effect on the calcium affinity of the ATPase, when measured under equilibrium calcium bind-and not some other phosphorylatable substrate, specifically modulates the Ca 2/ -ATPase. Stimulation of the ATPase by ing conditions (Fig. 6 ). From these results and others, it was concluded that PLB affects the kinetics of enzyme the PLB antibody also provided additional evidence that PLB, in the dephosphorylated state, acts as an inhibitor of activation by bound calcium rather than the actual calcium binding affinity (22). In support of this, it was found the enzyme at low ionized calcium concentration (202) .
Monoclonal antibodies recognizing the cytoplasmic domain that under equilibrium binding conditions, the calcium affinity of SERCA2a in cardiac sarcoplasmic reticulum of PLB (22, 88, 152, 159) thus substitute for PLB phosphorylation in reversing the suppressor effect of PLB on the vesicles (containing active dephosphorylated PLB) is identical to that of SERCA1a in fast-twitch skeletal muscle ATPase. Such antibodies have become a valuable experimental tool. For example, their use in intact cells allows sarcoplasmic reticulum vesicles, in which no PLB is present (22). Consistent with this, SERCA2a has the identical selective disruption of the PLB effect free from the potential influence of phosphorylation of other components, as calcium sensitivity in calcium transport assays as SERCA1a, when expressed independently of PLB (146, would occur during b-adrenergic stimulation (190) . In biochemical experiments requiring prolonged incubations, 222a). It was also found that SERCA2a, like SERCA1a, has two high-affinity calcium binding sites per ATP cata-such as those measuring equilibrium calcium binding to the calcium pump in membranes, interference from phosphalytic site and that PLB does not alter this fixed stoichiometry (22). The positive cooperativity of calcium binding to tase activities dephosphorylating phospholamban are obviated by use of the antibodies (22). SERCA is identical in cardiac and skeletal sarcoplasmic reticulum vesicles (22), which discounts the earlier proTo achieve a better understanding of the molecular interactions between PLB and the cardiac calcium pump, posal that PLB acts by altering calcium cooperativity (65; see also Refs. 107 and 174 in which no changes in calcium attempts have been made to functionally reconstitute the two proteins using purified components. Initial efforts by cooperativity of ATPase activation were found after phosphorylation of PLB by cAMP-or calcium/calmodulin-de-Inui et al. (78) to solubilize and recompose cardiac sarcoplasmic reticulum successfully reconstituted the calcium pendent protein kinases, respectively.) On the basis of these results, it was proposed that PLB acts by inhibiting pump activity and calcium loading rate but failed to reestablish the coupled modulatory effect of PLB phosphorythe slow isomeric transition after binding of the first calcium to the pump, without changing the overall equilib-lation on calcium transport; however, the reconstituted cardiac calcium pump transported calcium with threefold rium constant for calcium binding (22). Phosphorylation
09-01-98 19:46:53 pra APS-Phys Rev increased apparent calcium affinity, supporting the novel with the two calcium/catalytic site stoichiometry reported by Cantilina et al. (22) for native cardiac sarcoplasmic concept that PLB, when properly coupled, acts as an inhibitor of the calcium pump and that phosphorylation re-reticulum vesicles. Thus there is no evidence that PLB alters the coupling efficiency of the calcium pump as part leases this suppression. Subsequent attempts at reconstitution of purified native PLB or synthetic PLB with skele-of its reaction mechanism, as hypothesized in an early study (128). Although some success has been achieved in tal muscle or cardiac ATPases achieved only limited success in that significant effects of added PLB on the these latter reconstitution studies (152, 181, 182) , there is still room for improvement in that the inhibition of SERCA V max of the ATPases were noted (100, 187, 205, 206, 235) , which is not observed with intact cardiac membranes.
provided by PLB is no greater than 50% with use of these systems. In intact cardiac sarcoplasmic reticulum vesiIn more recent studies, some progress in reconstitution has been achieved. Reddy et al. (181) successfully cles, dephosphorylated PLB inhibits the calcium pump by 80% or more at the same low ionized calcium concentrareconstituted recombinant PLB purified from insect cells with SERCA1a isolated from rabbit skeletal muscle sarco-tions utilized. With the recent availability of milligram quantities of purified PLB and SERCA2a protein reagents, plasmic reticulum. In initial studies, purified SERCA1a was utilized because this enzyme was readily available however, the efficiency of the reconstitution procedures should improve as new approaches are tried. and PLB is equally effective in inhibiting SERCA1a and SERCA2a (62, 224) . Successful functional coreconstituIn an earlier attempt at reconstitution of SERCA2a purified from canine cardiac sarcoplasmic reticulum, it tion of purified proteins into phospholipid vesicles was demonstrated by satisfying the following criteria (181): was reported that a synthetic peptide composed of residues 1-31 of PLB (cytoplasmic domain) inhibited the V max PLB inhibited the ATPase at low (pCa 6.8) but not high (pCa 5.4) ionized calcium concentration, the inhibitory of the enzyme by 36% and that a synthetic peptide containing residues 28-47 of PLB, corresponding to most of effect was reversed by a monoclonal antibody to PLB, and both ATPase activity and calcium transport by the the transmembrane domain, lowered the calcium affinity (187). However, the reliability of the reconstitution system pump were inhibited by PLB, as occurs with native sarcoplasmic reticulum vesicles. Intact PLB was required to was not completely verified by the criteria defined above, and very high concentrations of peptides (100-300 molar meet these criteria for a successful reconstitution. Maximal calcium pump inhibition occurred at a molar stoichi-ratios of peptides to ATPase) were required for effects, suggesting that nonspecific interactions may have ocometry of approximately three PLB monomers per Ca 2/ -ATPase monomer in the reconstituted system (181). curred. Recently, another group (74, 75, 197) has reported that the cytoplasmic domain of PLB (residues 1-25) inhibNeither the cytoplasmic domain of PLB (residues 1-31 acetylated at the amino terminus) nor the membrane-its the V max of SERCA1a from rabbit skeletal muscle by a substantial amount (53%). In some studies (74, 75) , the spanning domain (residues 26-52) resulted in successful reconstitution. On the basis of the results obtained nonacetylated peptide was used, but in a more recent study, the acetylated peptide was required for the effect through reconstitution, it was concluded that both the cytoplasmic and transmembrane regions of PLB are es-(197). The physiological relevance of all of these results remains questionable, however, because as cited above, sential for normal calcium pump regulation (181) . Applying the same reconstitution method, Mayer et al. PLB in native cardiac sarcoplasmic reticulum has no significant effect on the V max of the enzyme measured at (152) recently reported success using synthetic PLB and SERCA1a.
saturating calcium concentration. Furthermore, using the well-characterized reconstitution system of Reddy and coIn a subsequent study, Reddy et al. (182) reported on the rapid purification of the canine cardiac Ca 2/ -ATPase workers described above (181, 182) , no significant effect of a synthetic peptide containing residues 1-31 of PLB by Cibacron blue affinity chromatography and successful functional coreconstitution of SERCA2a with recombi-(acetylated at the amino terminus) was found on SERCA1a (181) or SERCA2a (L. G. Reddy, D. L. Stokes, nant PLB. The same reconstitution criteria mentioned above were fulfilled and, in addition, phosphorylation of and L. R. Jones, unpublished data) activities by monitoring both ATP hydrolysis and calcium transport by the PLB by either cAMP-or calcium/calmodulin-dependent protein kinase reversed the PLB inhibition. No significant enzymes. Similar lack of effect of high concentrations of a synthetic peptide containing amino acids 1-32 of PLB phosphorylation of the purified cardiac calcium pump by cAMP-or calcium/calmodulin-dependent protein kinase on SERCA1a activity in fast skeletal muscle sarcoplasmic reticulum vesicles was noted by others (28, 234). In an was observed, whereas PLB was readily phosphorylated, accounting for the stimulation of calcium transport at low earlier report, it was shown that sarcoplasmic reticulum vesicles isolated from mouse atrial tumor cardiomyocytes ionized calcium concentration (182) . The phospholipid vesicles reconstituted with SERCA2a retained functional are essentially devoid of PLB but exhibit appreciable SERCA2a protein and calcium transport activity (88) . and structural integrity, in that two calcium ions were transported per ATP molecule hydrolyzed, which agrees With the use of this ''natural'' reconstitution system, it was shown that the cytoplasmic domain peptide (residues PLB and the pump are involved in the regulatory mechanism (26). Consistent with this concept, the polyanion 2-25) of PLB had no effect on calcium transport by these cardiac sarcoplasmic reticulum vesicles (88), nor did a heparin sodium stimulates calcium uptake into cardiac sarcoplasmic reticulum vesicles to the same level as PLB peptide composed of PLB residues 1-31, which was acetylated at the amino terminus like native PLB (unpub-phosphorylation (250), as does the application of a small concentration of negatively charged detergent (26). Tanlished data). Both peptides were ineffective when calcium transport was measured at both high and low ionized cal-nin, a plant phenol, also stimulates the Ca 2/ -ATPase and calcium uptake activities by decreasing the K Ca value with cium concentrations, in line with the view that the cytoplasmic domain of PLB by itself is insufficient to inhibit no effect on the V max , leading to the hypothesis that the acidic groups of tannin interact with basic groups of PLB the calcium pump of cardiac sarcoplasmic reticulum in any way that reflects the action of native PLB in the sarco-to disrupt its inhibitory effect on the calcium pump (27).
Another polyphenol, quercetin, reverses phospholamban plasmic reticulum membrane.
Attempts have been made to uncouple PLB from the inhibition of the Ca 2/ -ATPase in cardiac sarcoplasmic reticulum vesicles by inducing a similar increase in calcium Ca 2/ -ATPase in cardiac sarcoplasmic reticulum vesicles by different biochemical methods to better understand the sensitivity, and indirect evidence has been presented suggesting that quercetin interacts with the nucleotide bindnature and sites of interaction. Trypsin treatment, which degrades PLB between lysine residue 3 and arginine resi-ing site of the ATPase (154). Cross-linking experiments by James et al. (84) with a PLB photoaffinity labeling due 25 (193) removing the cytoplasmic domain (241), increased the calcium sensitivity of calcium transport simi-probe first indicated that lysine residue 3 of PLB in the cytoplasmic domain binds to a region of the Ca 2/ -ATPase lar to PLB phosphorylation, suggesting that this region of PLB is involved in the inhibition of the calcium pump (73, just downstream of the acylphosphorylation site at aspartate residue 351. Taken together, the results suggest that 107). Mechanistic interpretations of these experiments, however, are complicated by the fact that trypsin also PLB may inhibit the Ca 2/ -ATPase through electrostatic interactions involving basic residues of the PLB cytosolic degrades the calcium pump. In an attempt to localize the cytoplasmic residues of PLB that interact with the Ca 2/ -domain and acidic residues of the Ca 2/ -ATPase near the ATP binding site and the phosphorylated aspartic acid ATPase, an anti-PLB monoclonal antibody that reverses the PLB inhibition was used in a competitive binding assay (see mutagenesis results discussed below). The dynamic equilibrium between phospholamban pentamers and to map the PLB epitope to amino acids 7-16 (159). However, it is still not tested if site-specific antibodies to other monomers in the plane of the lipid membrane also appears to be controlled by electrostatic interactions. Phosphoryregions of the cytoplasmic domain of PLB are capable of disrupting the inhibitory interaction with the Ca 2/ -ATP-lation of PLB or buffers of high ionic strength promotes pentameric stability of the protein (34). ase. These results substantiate the importance of the cytoplasmic domain of PLB for reversal of the inhibition of Important new insights on mechanisms of calcium pump regulation have been provided through the use of the calcium pump by phosphorylation or antibody. In vitro reconstitution studies suggest, however, that anchoring cellular coexpression of recombinant PLB with SERCA enzymes. Fujii et al. (52) found that coexpression of PLB of the cytoplasmic domain to the transmembrane region of PLB is required for effective functional coupling of PLB with SERCA2a in COS-1 cells lowered the calcium sensitivity of the enzyme in calcium transport assays conto ATPase inhibition (88, 181) . In coexpression studies, coupling of PLB to ATPase inhibition could be achieved ducted with microsomal membrane preparations, confirming by recombinant methods that PLB is an inhibitor when severely truncated or altered cytoplasmic domains were attached to the transmembrane domain (102) . These of the calcium pump. The effect of PLB on the calcium affinity of the smooth muscle isoform of the Ca 2/ -ATPase results were explained by the proposal of the existence of a circuit of regulatory interactions involving communi-(SERCA2b) has been compared with that of the cardiac isoform (SERCA2a) in another cell transfection system, cation between cytoplasmic and transmembrane domains in both PLB and SERCA (102, 103) . and both isoforms were found to exhibit an approximately twofold decrease in apparent calcium affinity when coexThe large change in the isoelectric point of PLB induced by phosphorylation (90) suggests that charge-pressed with PLB (230). The efficient functional coupling of PLB to SERCA2b in the transfection system (230) sugcharge protein interactions may be important for the ability of PLB to inhibit the calcium pump. A change in surface gests that the relatively poor coupling between the two proteins in intact smooth muscle (178, 239) is not because membrane potential, in fact, occurs after phosphorylation of PLB and, under high ionic strength conditions, both of structural differences between SERCA2a and SERCA2b. With use of the recombinant coexpression systhe surface membrane potential and PLB phosphorylation effects on the apparent calcium affinity of the Ca 2/ -ATP-tem, the issue of the role of PLB in regulating the calcium sensitivity of the cardiac calcium pump vis-à -vis the V max ase are attenuated, supporting the notion that electrostatic interactions between the cytoplasmic domain of of the enzyme was reassessed by Odermatt et al. (172) . It was observed that phosphorylation of PLB in microsomes for functional interaction with the cardiac Ca 2/ -ATPase. Phospholamban mutants coexpressed with the cardiac from HEK-293 cells coexpressing PLB and SERCA2a decreased the K Ca value in transport assays by approxi-Ca 2/ -ATPase localized 13 amino acid residues between sequence positions 2-18 of PLB as important for the funcmately twofold but had no effect on the V max of the enzyme at saturating calcium concentration. Similar results were tional association between the two proteins (225). Point mutation of four positively charged residues, one negaobserved when PLB was phosphorylated by cAMP-dependent protein kinase, by calcium/calmodulin-dependent tively charged residue, four hydrophobic residues, two alanine residues, and the phosphorylated residues (serine protein kinase, or by both kinases together, and when native cardiac vesicles were analyzed in parallel experi-16 and threonine 17) in this region all resulted in loss of the inhibitory effect of PLB on calcium transport by the ments, the same effect on the K Ca value, but not V max , was obtained (172) . Likewise, coexpression of phospholam-cardiac Ca 2/ -ATPase (225). This result emphasizes the fact that considerable structural specificity is required to ban with SERCA2a in Sf21 insect cells increased the K Ca value obtained for activation of ATPase activity or cal-maintain functional PLB coupling and that hydrophobic as well as electrostatic interactions are important. Based cium transport with no effect on the V max of the enzyme (12). Overexpression of PLB in cultured neonatal rat on these results, the authors (225) concluded that this cytoplasmic region of PLB (residues 2-18) is essential for cardiomyocytes by infecting cells with PLB-encoding adenovirus also increases the K Ca value with no effect on the functional association with the Ca 2/ -ATPase. Somewhat surprisingly, however, in a subsequent study it was ob-V max of the enzyme (60b). Thus, with the use of the purified proteins coreconstituted biochemically (181, 182) , with served by Kimura et al. (102) that the cytoplasmic domain of PLB could be replaced with a foreign epitope or deleted the use of molecular coreconstitution in cultured cells (12, 60b, 172) , and with the use of native sarcoplasmic entirely with functional coupling of the PLB transmembrane domain to SERCA pumps preserved. In fact, some reticulum vesicles (22, 172), recent carefully controlled studies confirm the conclusion that the main functional of the mutant PLB constructs examined, which lacked the native cytoplasmic domain, were actually stronger inhibieffect of PLB is to regulate the calcium sensitivity of the SERCA2 enzyme.
tors of SERCA2a activity than was wild-type PLB. For example, addition of the hemagglutinin epitope to the Mutational analyses have also been conducted with cellular coexpression systems to localize molecular do-transmembrane sequence of PLB containing residues 28-52 ''supershifted'' the apparent calcium affinity to values mains important for PLB/calcium pump interactions. To localize residues in the Ca 2/ -ATPase required for func-lower than those observed with native PLB. From these observations, Kimura et al. (102) proposed that the intertional coupling to PLB, PLB was coexpressed individually with SERCA1a, SERCA2a, and SERCA3 and found to de-action between the membrane-spanning domains of PLB and SERCA2a inhibits SERCA2a by lowering its apparent crease the calcium sensitivity of SERCA1a and SERCA2a, but not SERCA3 (224) . In the PLB uncoupled states, calcium affinity. It was also suggested that the cytoplasmic domain of PLB is by itself not inhibitory, but SERCA1a and SERCA2a had identical high calcium affinities, but the apparent calcium affinity of SERCA3 was instead modulates the inhibitory interactions in the transmembrane domains through a long-range coupling proalready low and unaffected by PLB. By analysis of SERCA2/SERCA3 chimeric proteins, regions of the Ca 2/ -cess (102).
A puzzling but at the same time intriguing question ATPase molecule critical for the functional coupling to PLB were localized by Toyofuku et al. (224) to two cyto-is the role of the PLB pentamer in calcium pump regulation (31). Recent experiments (12, 103) have led to the plasmic domains, one containing residues 336-412 (acylphosphorylation domain) and the other comprised of resi-conclusion that the PLB monomer, not the pentamer, may actually bind to and inhibit the calcium pump in the sarcodues 467-762 (nucleotide binding/hinge domain). Mutagenesis experiments by Toyofuku et al. (226) further plasmic reticulum membrane. With the use of either the Sf21 insect cell system (11, 12) or HEK-293 cells (103) specified the essential amino acids in the acylphosphorylation domain of the Ca 2/ -ATPase interacting with PLB as for coexpression of PLB with SERCA2a, changing leucine residue 37 in the leucine zipper region of PLB (Fig. 5 ) to residues 397-402 and pointed to the importance of charged side chains in the interaction. Interestingly, the alanine (L37A-PLB) depolymerized the protein in the plane of the phospholipid membrane (34), while at the SERCA2a peptide labeled by the PLB photoaffinity probe by James et al. (84) encompasses the critical ATPase inter-same time giving a stronger inhibition of the calcium pump at low ionized calcium concentration than did coexaction site later identified in the mutagenesis experiments of Toyofuku et al. (226) , suggesting that lysine residue 3 pression of wild-type, pentameric phospholamban.
Whereas coexpression of wild-type PLB with the Ca 2/ -of PLB in the cytoplasm may bind directly to residues 397-492 of the ATPase.
ATPase increased the K Ca value required for pump activation by approximately twofold, coexpression of L37A-PLB Cellular coexpression of recombinant proteins has also been used to identify amino acids of PLB important with the Ca 2/ -ATPase increased the K Ca value by four-to 12, 103) . The inhibition of the Ca 2/ -ATPase by brane residues of SERCA2a that interact directly with the putative inhibitory transmembrane helical face of PLB will L37A-PLB was shown to be reversed by addition of the PLB monoclonal antibody (12), demonstrating that the be essential for a complete understanding of the mechanism by which PLB regulates the activity of the calcium basic mechanism of inhibition of the Ca 2/ -ATPase by wildtype PLB and L37A-PLB was similar. From such results, pump (197a).
Given the evidence that suggests that not only the it was hypothesized that PLB monomers and pentamers are in dynamic equilibrium in the lipid bilayer (34) and PLB cytoplasmic domain but also the transmembrane domain serves a functional role beyond tethering the cytothat PLB monomers preferentially bind to the calcium pump and inhibit calcium transport in the sarcoplasmic plasmic domain to the sarcoplasmic reticulum, what are the structural details of the PLB/Ca 2/ -ATPase interaction? reticulum membrane (12, 103).
Kimura et al. (103) performed scanning-alanine muta-Related questions, given the model that dephosphorylated monomeric PLB is capable of interacting directly with genesis of the membrane-spanning residues of PLB and confirmed the observation (194) that leucines 37, 44, and the Ca 2/ -ATPase to inhibit its calcium pumping activity, involve determining the stoichiometry of PLB to the Ca 2/ -51 and isoleucines 40 and 47 repeating every three or four residues along one face of the transmembrane helix were ATPase and, moreover, the role of oligomeric complexes of the Ca 2/ -ATPase itself (4) to its own function. Early the pentamer-stabilizing residues (Fig. 5 ). These investigators then examined the functional consequences of the indirect estimates using phosphate incorporation into both PLB and the Ca 2/ -ATPase for quantitation suggested PLB point mutations by coexpressing all of the mutated proteins with SERCA2a in HEK-293 cells. A remarkable a 1:1 stoichiometry of PLB pentamers to Ca 2/ -ATPase monomers (141, 209) , but a more recent indirect study cyclical pattern was noted, in that mutations on one face of the helix diminished or completely prevented inhibitory using densitometric determination of the Ca 2/ -ATPase concentration and mobility shift estimates of the PLB coninteractions with the calcium pump, whereas mutations on the opposite face of the helix activated inhibitory centration indicated 0.4 mol of PLB pentamer for every mole of Ca 2/ -ATPase monomer (32). The concept of a interactions with the calcium pump (103) . Most of the mutations that enhanced inhibitory interactions with the fixed stoichiometry between PLB and the calcium pump in the sarcoplasmic reticulum membrane may be a ''red calcium pump were the monomer-producing mutations located in the leucine/isoleucine zipper region (194) herring,'' however, because of the relatively weak binding affinity between the two proteins (78, 121, 182), the ease (L37A-PLB, I40A-PLB). These monomeric mutants were termed ''supershifters'' (102, 103) because they decreased of dissociation of the functional complex in the plane of the sarcoplasmic reticulum membrane (142, 192) , the the apparent calcium affinity of SERCA2a about twofold more effectively than did wild-type PLB. Based on these dynamic equilibrium between PLB pentamers and monomers themselves in the plane of the membrane (34), and results, Kimura et al. (103) independently concluded that PLB monomers are the active species inhibiting SERCA2a the uncoordinated expression of the two proteins in vivo under certain conditions (104, 112) . in the sarcoplasmic reticulum membrane. An equally important observation of Kimura et al. (103) was the identiAlthough the true stoichiometry between PLB and the Ca 2/ -ATPase remains ill defined, it has been specufication of several ''loss-of-function'' mutants of PLB (i.e., L31A-PLB, N34A-PLB, L42A-PLB) that arose from chang-lated that dephosphorylated PLB might restrict Ca 2/ -ATPase conformational freedom and thereby suppress ing residues on the face of the transmembrane helix opposite from the pentamer-stabilizing face. These loss-of-its activity (45). In support of this hypothesis, recent experiments by Thomas and co-workers (236) using function mutants were no longer able to inhibit the calcium pump effectively, suggesting for the first time the time-resolved phosphorescence anisotropy indicate that there is a distribution of oligomeric complexes of the presence of essential amino acid residues in the transmembrane region of PLB that might be required for direct Ca 2/ -ATPase in sarcoplasmic reticulum, with large stationary aggregates and slowly rotating oligomers in addifunctional interactions with the transmembrane segments of SERCA2a. In fact, on the basis of these results (103) tion to the highly dynamic monomers. Phosphorylation of PLB increased the rotational mobility of SERCA2a as and those from their earlier study (102) , it was concluded that the transmembrane region of PLB containing the loss-a result of a decrease in large aggregates, supporting a model in which PLB phosphorylation releases the Ca 2/ -of-function mutational sites is the domain directly responsible for inhibiting the Ca 2/ -ATPase and lowering its ap-ATPase from a kinetically unfavorable associated state (236), perhaps the kinetic state after the binding of the parent calcium affinity. The cytoplasmic domain of PLB, on the other hand, was proposed to modulate the inhibi-first calcium ion (22). Reciprocal aggregation (pentamer formation) of phospholamban by phosphorylation (34) tory interactions in the transmembrane domain through long-range coupling (102) . This would explain why the with resultant deaggregation and activation of the Ca 2/ -ATPase (236) (Fig. 7) is consistent with the recent PLB cytoplasmic domain of PLB by itself is insufficient to inhibit the ATPase (88, 181) . Identification of the transmem-mutagenesis studies cited above in which expression FIG. 7. Cartoon model of PLB mechanism of action. Dephosphorylated PLB monomer inhibits SERCA2a (12, 103) by binding to cytoplasmic and membrane domains of pump, stabilizing enzyme in E 2 conformation, and causing enzyme inhibition and pump aggregation (236). Phosphorylation of PLB reverses calcium pump inhibition favoring association of PLB monomers into pentamers (34). Dark shading in membrane region of PLB indicates face of transmembrane helix interacting with calcium pump (103) , and open area designates face of helix containing leucine/isoleucine zipper residues (194). K 1 and K 2 are hypothetical dissociation constants for PLB pentamer to monomer conversion and for PLB monomer binding to SERCA2a, respectively, as explicitly proposed in Ref. of PLB with depolymerizing mutations gives stronger aggregation-based mechanism (236, 237) (Fig. 7) . It should be pointed out that Chu et al. (29) recently overinhibition of the Ca 2/ -ATPase than does expression of wild-type PLB (12, 103). The inhibition by PLB due to expressed the monomeric mutant C41F-PLB in transgenic mouse ventricle and noted no stronger supinduction of Ca 2/ -ATPase lateral aggregation was further supported by a study of comparative molecular dy-pression of contractility than that achieved with overexpression of wild-type PLB. This negative result is prenamics in mouse atrial tumor versus ventricular sarcoplasmic reticulum, which exploited the absence of PLB dictable, however, because C41F-PLB, although monomeric (51, 194), is no more effective than wild-type PLB in the atrial membranes as a control for the ventricular membranes that contain PLB in levels similar to other in inhibiting the calcium pump (225). This is probably because the interaction domain with the ATPase is parmammals (237). The model proposed from these results suggests a structural and functional perturbation of the tially perturbed with this mutation, even though the protein is monomeric (103). Ca 2/ -ATPase through electrostatic interactions with PLB that affect self-association of the Ca 2/ -ATPase (236, Other experiments appear to provide results that conflict with the finding that dephosphorylated PLB inhibits 237), resembling the general mechanism of many signal transduction processes that involve lateral association SERCA2a by aggregating the enzyme. Studies using either time-resolved phosphorescence polarization (48) or of membrane proteins (45). Mutagenesis of PLB (12, 103) combined with molecular dynamics results (34, 236, 237) spin-label electron paramagnetic resonance (167) have reported a decrease in the rotational dynamics of the suggest that the PLB monomer may be the most active species promoting Ca 2/ -ATPase aggregation/inactiva-Ca 2/ -ATPase associated with phosphorylation of PLB, prompting the suggestion that PLB phosphorylation actution. Phosphorylation of PLB drives its equilibrium toward pentamers (34), which may be relatively ineffec-ally enhances interaction between Ca 2/ -ATPase chains either by increasing protein-protein interactions or by altertive inhibitors of the Ca 2/ -ATPase compared with monomers (103) . Whether the pentamer by itself (in the ing the conformation of Ca 2/ -ATPase chains within a stable oligomeric state (167). These findings, however, are absence of any monomers) is capable of inhibiting the Ca 2/ -ATPase remains to be determined. In this model of more consistent with PLB being an activator of the Ca 2/ -ATPase rather than an inhibitor, and also are difficult PLB interaction with the calcium pump, the pentamer in the membrane can be viewed as a reservoir for mono-to reconcile with the observation that SERCA1a and SERCA2a have identical calcium affinities when PLB is mers (103) , which dissociate from the pentamer in the dephosphorylated form (34), diffuse in the plane of not present (146) or is inactivated (22). Moreover, other recent results using time-resolved phosphorescence anmembrane, and then bind to and inhibit the Ca 2/ -ATPase at low ionized calcium concentrations (12, 103) by an isotropy to investigate the effects of the nonionic deter- -(236, 237). To resolve these discrepancies and better define the correlation between PLB and Ca 2/ -ATPase oligo-ATPase activity and calcium transport across the sarcoplasmic reticulum, in vivo experiments demonstrate that merization, molecular dynamics within the sarcoplasmic reticulum, and the regulation of calcium transport, further PLB is a key regulator of myocardial relaxation and, as more recently demonstrated, force development as well experiments will be required utilizing the latest technologies for detecting and quantitating protein-protein interac- (144) . Early studies of microsomal membranes isolated from 32 P-perfused mammalian hearts demonstrated that tions.
The intriguing pentameric quaternary arrangement of PLB is the major sarcoplasmic reticulum protein phosphorylated in intact cardiac muscle in response to b-ad-PLB subunits and its resemblance to a pore-forming structure (7, 8, (193) (194) (195) invite the question whether PLB may renergic stimulation (122, 134). Phosphorylation of PLB correlated temporally, over a time course of seconds, with regulate calcium flux independent of Ca 2/ -ATPase activity by functioning as a channel (64a, 115) . Supporting the the ability of the b-agonist isoproterenol to accelerate the rate of relaxation of the heart (134) and occurred as a structural model of PLB as a channel, the crystal structure of a five-stranded coiled-coil domain in the cartilage oligo-consequence of activation of cardiac b 1 -adrenergic receptors selectively (2, 248) . When Ca 2/ -ATPase activity was meric matrix protein was recently determined (149) and bears a striking similarity to the transmembrane hydropho-analyzed in sarcoplasmic reticulum vesicles isolated from hearts subjected to b-adrenergic stimulation, in which bic pore structure proposed for PLB (194, 195) . The observed 2-6 Å internal diameter of the pore in this crystal care was taken to prevent dephosphorylation of PLB during the preparation of membranes, it was observed that structure and the presence of 13 water molecules distributed within the hydrophobic pore (149) provide an experi-both Ca 2/ -ATPase (134) and calcium uptake (119) activities were increased as a result of PLB phosphorylation. mental basis to validate the plausibility of the structural model of PLB as a calcium channel. Furthermore, the regu-Furthermore, the stimulation of calcium pump activity occurred most prominently at low ionized calcium conlar rings of conserved glutamine residues and constrictions of the internal pore diameter caused by side chains at posi-centration (55, 119, 134) , showing that for PLB phosphorylated in vivo, like the protein phosphorylated in vitro, the tions a and d of the coiled-coil residue pattern may suggest the physical basis for ion selectivity and gating (149).
main effect is on the calcium sensitivity of the ATPase, not on the V max . In other experiments, it was demonSingle-channel recording experiments have, in fact, demonstrated calcium-selective channel behavior for PLB strated that dephosphorylation of PLB, rather than of other cardiac protein substrates such as troponin I, C-(115), and early attempts to directly express PLB in cellbased expression systems resulted in cell lysis (33), con-protein, or phospholemman (56, 155, 219, 252), most closely paralleled termination of the mechanical effects sistent with the ability of PLB to spontaneously form membrane pores. However, there is no evidence yet that of b-adrenergic stimulation. Furthermore, cholinergic stimulation, which reverses the functional effects of b-PLB functions as a channel or passive pore in the sarcoplasmic reticulum membrane (12, 181). The good correla-adrenergic stimulation, attenuated phosphorylation of PLB and Ca 2/ -ATPase activity at the same time that it tion of calcium uptake with changes in ATPase activity in in vitro vesicle systems supports a simple model in increased the half time of relaxation (136) . Thus, during b-adrenergic stimulation of the heart, phosphorylation of which the Ca 2/ -ATPase is regulated by phosphorylationreversible interaction with PLB and does not require for PLB occurs rapidly, is regulated dynamically, and causes an increased rate of calcium transport into the sarcoplasexplanation a complex model involving putative PLB calcium channel activity (10). The fact that the PLB monomer mic reticulum. The resultant increase in rate of lowering of the cytoplasmic calcium concentration can account for is a stronger inhibitor of calcium transport than is the pentamer (12, 103) also argues against any kind of channel the increased rate of myocardial relaxation produced by b 1 -agonists (215). activity being required for calcium pump inhibition. Nevertheless, the recent appreciation that coiled-coil struc-
The amino acid residues of PLB phosphorylated in beating mammalian myocardium in response to b-adrentures in proteins can fulfill many functions, from molecular stalks and scaffolding (e.g., kinesin and fibrin) to di-ergic stimulation were localized by monoclonal antibody affinity purification of the 32 P-labeled protein from permerization and selective interaction (e.g., bZip or basic region leucine zipper transcription factors) to a dynamic fused guinea pig hearts followed by phosphoamino acid analysis and direct protein sequencing (242). It was obhinge (e.g., influenza hemagglutinin) (37a, 145) , suggests that all of the functional attributes of PLB may not yet be served that only serine-16 and threonine-17 were phosphorylated, indicating that in intact myocardium, b-adrenfully revealed. ergic stimulation results in PLB phosphorylation by both predicted from results of calcium uptake assays utilizing sarcoplasmic reticulum vesicles (116, 174, 209) . Under cAMP-dependent protein kinase (at serine-16) and calcium/calmodulin-dependent protein kinase (at threonine-physiological conditions, inhibition of the major phosphatase that dephosphorylates PLB, the type 1 phosphatase 17). During b-adrenergic stimulation with isoproterenol, phosphorylation at serine-16 precedes that at threonine-(PP1) associated with cardiac sarcoplasmic reticulum (147) , is apparently required to realize significant phos-17, but at steady state, both sites are phosphorylated in approximately equimolar amounts (242). Talosi et al. phorylation of PLB at threonine-17. Inhibition of PP1 activity associated with sarcoplasmic reticulum by cAMP-(219) subsequently showed that during termination of badrenergic effects, dephosphorylation at serine-16 also elevating agents occurs as a consequence of release of the catalytic subunit of the phosphatase from the memprecedes that at threonine-17, and proposed that the phosphorylation state of serine-16 correlates most closely with brane after phosphorylation of the regulatory subunit by cAMP-dependent protein kinase (1, 69) , and also as a rethe mechanical effects. Immunoblotting of microsomes from hearts subjected to b-adrenergic stimulation re-sult of phosphorylation of phosphatase inhibitor 1 by cAMP-dependent protein kinase, which in the phosphoryvealed 10 discrete mobility steps induced in the pentameric form of the protein (Fig. 4) , confirming the additive lated state is a potent inhibitor of PP1 catalytic activity (170) . Supporting this mechanism, dephosphorylation of phosphorylation of both sites on each monomer composing the pentamer during the time course of b-agonist stim-PLB in cardiac myoctyes is greatly stimulated by inactivation of cAMP-dependent protein kinase (252). For realizaulation (242) and refuting an earlier proposal that there is no dephospho form of PLB in vivo in the basal unstimu-tion of the maximal contractile effect of PLB phosphorylation in intact myocardium, it thus appears that phosphorylated state (127). Phosphorylation of PLB by cAMP-dependent protein kinase and calcium/calmodulin-dependent lation of both serine-16 and threonine-17 is required and that this requirement is only fulfilled by cAMP-dependent protein kinase was also observed by use of the backphosphorylation technique in hearts from live animals ad-mechanisms involving an interplay between protein kinases and phosphatases (164). ministered isoproterenol (96) . Thus dual phosphorylation of PLB occurs in vivo, as well as in vitro, with PLB regulatFrom studies of the types described above, it was fairly certain that PLB was a major phosphoprotein particing relaxant properties of the heart in a graded fashion by its incremental phosphorylation.
ipant in the regulation of cardiac contractility. However, because of the myriad of proteins phosphorylated in intact A vexing problem concerning PLB phosphorylation in intact muscle is that whereas PLB is readily phosphory-heart in response to b-adrenergic stimulation, it was always impossible to be absolutely certain that phosphorylated in vitro at threonine-17 by calcium/calmodulin-dependent protein kinase independent of any requirement lation of PLB, by and of itself, was sufficient to alter myocardial contractile properties (97) . In more recent work, for prior phosphorylation at serine-16 by cAMP-dependent protein kinase, in intact muscle under physiological condi-the prime importance of PLB phosphorylation has been unambiguously demonstrated by two different aptions, PLB is only phosphorylated significantly by agents that elevate cAMP (135) . Positive inotropic agents that proaches. In the first, ventricular myocytes were dialyzed with a monoclonal antibody to PLB that stimulates calincrease intracellular calcium concentration sufficiently high to activate calcium/calmodulin-dependent protein ki-cium uptake into sarcoplasmic reticulum at low ionized calcium concentration, and intracellular calcium trannase (high extracellular calcium concentration, calcium channel agonists, a-adrenergic agonists), but which do sients were measured with the calcium-sensitive dye fura 2 (190) . Dialysis of myocytes with the antibody signifinot increase cAMP, have no effect on PLB phosphorylation in intact hearts (133, 135, 166, 232, 233, 243) . This cantly increased the amplitude and decreased the duration of the calcium transient, and effects of b-agonist stimparadox was recently addressed by Mundina-Weilenmann et al. (164), who took advantage of antibodies that distin-ulation by isoproterenol on the calcium transient were virtually eliminated by the antibody (190) . Thus removal guish between serine-16-phosphorylated PLB and threonine-17-phosphorylated PLB (38) to reassess mechanisms of the inhibitory effect of PLB on the calcium pump of sarcoplasmic reticulum was proposed to be sufficient to regulating PLB phosphorylation at these two sites in perfused hearts. Notably, when hearts were perfused at ele-elicit most of the effects of b-adrenergic stimulation on the intracellular calcium transient in intact cardiac myovated extracellular calcium concentration in the presence of the phosphatase inhibitor okadaic acid, phosphoryla-cytes (190) . Consistent with this conclusion, it was recently shown that overexpression of PLB in cultured cartion of threonine-17 of PLB readily occurred, and without any requirement for phosphorylation at serine-16. A sig-diac myocytes by infection of cells with PLB-encoding adenovirus decreased the amplitude and increased the nificant decrease in the half-relaxation time coincided with this unique phosphorylation of threonine-17 (164). duration of the calcium transient (60b) .
In the second approach, a PLB gene knockout stratThus phosphorylation of PLB at threonine-17 alone is sufficient to increase the cardiac relaxation rate, as originally egy was implemented by Kranias and co-workers (144) create a transgenic mouse lineage completely devoid of the calcium pump for calcium, with no change in the V max of the enzyme detected (144) . In another study, the control the protein. The profound influence of PLB on contractility was then demonstrated in an elegant series of experi-and transgenic mouse hearts were found to contain identical levels of the calcium pump protein (29a). Thus recent ments using this model (reviewed in Refs. 95 and 114) . Perfused hearts from PLB knockout mice had dramatic in vitro and in vivo studies using state-of-the-art technologies produce consistent results demonstrating the leading contractile changes in comparison with hearts from littermate control mice. Both rates of tension development role of PLB in transmitting b 1 -adrenergic effects by modulating the calcium sensitivity, but not the V max , of the and rates of myocardial relaxation were increased and, moreover, b-agonist stimulation of these transgenic hearts calcium pump. by isoproterenol was sharply attenuated, due to the fact that the basal state of contractility in the transgenic hearts VII. PHOSPHOLAMBAN EXPRESSION IN HUMAN was already close to the maximal level. Similar changes HEART FAILURE were shown in live PLB knockout mice by use of echocardiography (66) . The results obtained from transgenic mouse hearts completely lacking the PLB protein (66, 144) Despite the importance of PLB to normal cardiac function, its role in the pathophysiology of human heart are consistent with results from normal cardiomyoctyes dialyzed with the highly specific anti-PLB monoclonal an-disease remains unknown. Two of the physiological hallmarks of human heart failure are extended calcium trantibody (190) , demonstrating that PLB is a key suppressor of basal myocardial contractility and that phosphorylation sients and prolonged myocardial relaxation (158), yet in one study, the magnitude of the PLB effect on calcium of PLB can account for most of the contractile effects of b 1 -adrenergic stimulation on the heart, including both uptake was observed to be the same in normal versus failing heart sarcoplasmic reticulum vesicles from papositive inotropic effects and enhanced relaxation (95, 114) . The positive inotropic effect associated with b-ad-tients with idiopathic dilated cardiomyopathy (161). Movsesian et al. (161) showed that a monoclonal antibody to renergic stimulation of the heart arises from increased calcium loading by the sarcoplasmic reticulum, which PLB stimulated calcium uptake equally well at low ionized calcium concentration with microsomes isolated from makes more calcium available for calcium release. The augmented calcium release promotes more rapid calcium normal human hearts or with microsomes from patients with dilated cardiomyopathy. Consistent with these rebinding to troponin, stimulating tension development. The increased rate of muscle relaxation is a direct conse-sults, five other studies found no change in protein expression levels of either PLB or the Ca 2/ -ATPase in hearts quence of the accelerated rate of calcium removal from the cytoplasm, allowing calcium to be rapidly unbound from patients with end-stage ischemic or dilated cardiomyopathy (17, 46, 132, 162, 188). Earlier studies detected from troponin (114, 210) . Consistent with this idea, targeted overexpression of PLB to mouse ventricle (95a) or a decrease in PLB mRNA levels in samples from failed human hearts (6, 43), but this decrease in PLB mRNA is mouse atrium (168) in transgenic animals prolongs contraction time and depresses contractility in both tissues, not associated with a decrease in PLB protein (46, 132) .
However, one study found that the PLB protein level was whereas b-adrenergic effects are amplified. Although badrenergic-mediated contractile effects are strongly atten-decreased slightly (18%) in hearts from patients with dilated cardiomyopathy (153) , and two studies (64, 153) uated in PLB knockout mice, some contractile response to catecholamines does persist both in live animals (66) suggested that the protein level of the calcium pump may be decreased more substantially (36-41%). In two studies, and in isolated myocytes (245a), suggesting that phosphorylation of proteins other than PLB (troponin I, ryano-calcium uptake (64, 188) and Ca 2/ -ATPase (188) activities were decreased in tissue preparations from heart failure dine receptor, phospholemman, and dihydropyridine-sensitive calcium channel) may also play a role in regulating patients, but coupling of the calcium pump to PLB was not analyzed, and there was disagreement on whether or contraction-relaxation dynamics of heart cells (245a).
The PLB knockout mouse model has also proven to not PLB and SERCA2a protein levels were changed. Some of the differences between laboratories are probably a be useful in confirming the mechanism of action of PLB in inhibiting the Ca 2/ -ATPase of sarcoplasmic reticulum consequence of the difficulties involved in obtaining adequately preserved myocardial samples from human pamembranes. Calcium transport into sarcoplasmic reticulum vesicles was compared between homogenates from tients. Nevertheless, all groups seem to agree that in failed human myocardium, the protein expression level of PLB transgenic mouse hearts lacking PLB and homogenates from littermate controls containing normal amounts of is unchanged or only negligibly affected (17, 46, 132, 153, 162, 168) , even though in certain animal models of heart the protein (144) . Calcium uptake into sarcoplasmic reticulum vesicles from PLB-deficient transgenic mouse hearts failure the level of PLB can be downregulated substantially (184) . Although the intrinsic mechanism of PLB couwas augmented, but only at low ionized calcium concentration, reflecting an increase in the apparent affinity of pling to the Ca 2/ -ATPase is unaltered in normal and failed 
